A Clinical trial to study the effects of two drugs,Nimbadi guggulu and Pathyashadangam Ghanavati in patients with Migraine.
Phase 2
- Conditions
- Health Condition 1: G439- Migraine, unspecified
- Registration Number
- CTRI/2021/06/034009
- Lead Sponsor
- DR AMRITHA MOHA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients aged 16 â?? 60 years irrespective of gender religion and socioeconomic status will be selected
Patients presenting with clinical features of Ardhavabhedaka will be selected
Exclusion Criteria
Patients having other types of Shirashula apart from Ardhavabhedaka will be excluded.
Patients suffering from secondary headaches like sinusitis, meningitis etc. will be excluded.
Patients with any other systemic diseases and pregnancy will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bheda Todavat Shula( Intensity of pain) <br/ ><br>Duration of single episode <br/ ><br>Frequency of attack <br/ ><br>Photophobia <br/ ><br>Nausea <br/ ><br>Vomiting <br/ ><br>Timepoint: 90 DAYS <br/ ><br>
- Secondary Outcome Measures
Name Time Method OT APLICABLETimepoint: NOT APLICABLE